Nii Osae of Mindbeam AI Describes Project to Identify Promising New Treatments. Artificial intelligence promises to reshape drug discovery, including by helping to identify safer options to common medications in a fraction of the time. Nii Osae, founder and CEO of Mindbeam AI, describes how AI models produced promising insights into pain-relief drug research at his firm.
First seen on govinfosecurity.com
Jump to article: www.govinfosecurity.com/how-ai-speed-up-discovery-safer-pain-relief-options-a-32222
